novel agents in the pipeline for cll & lymphoma
Published 7 years ago • 880 plays • Length 14:07Download video MP4
Download video MP3
Similar videos
-
24:17
combination of novel agents in cll: is this the final answer?
-
21:19
other new molecules in the cll pipeline: pi3k inhibitors, syk inhibitors, etc.
-
27:18
novel treatment options in cll
-
16:24
chemotherapy vs novel agents in young cll patients: is there still a role for chemo?
-
13:55
debate: optimal approach for the management of cll patients with del(17p) - novel agents
-
15:41
novel agents in follicular lymphoma
-
22:26
key novel agents for relapsed diffuse large b-cell lymphoma
-
18:49
use of novel prognostic markers in practice for cll
-
28:25
tkis, apoptotic enhancers, and other small molecules in the pipeline
-
20:21
novel agents in elderly cll patients: should the approach be different?
-
19:58
incorporating novel agents into the therapy of follicular lymphoma
-
22:19
key insights in chronic lymphocytic leukemia: from lymphoma & myeloma 2018
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
49:01
chronic lymphocytic leukemia: case discussions
-
23:28
richter’s syndrome: what are the options?
-
19:42
treatment options for the young cll patient with deletion 17p: do they need a different approach?
-
21:38
risk assessment in the era of novel agents: what prognostic factors are clinically relevant?
-
23:25
velocity vlog: transforming the diagnosis and treatment of cll
-
2:37
allo-hsct for cll in the era of novel agents